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Objectives The purpose of this study was to assess the diagnostic accuracy of blood oxygen-level dependent (BOLD) MRI in
suspected coronary artery disease (CAD).
Background By exploiting the paramagnetic properties of deoxyhemoglobin, BOLD magnetic resonance imaging can detect
myocardial ischemia. We applied BOLD imaging and first-pass perfusion techniques to: 1) examine the patho-
physiological relationship between coronary stenosis, perfusion, ventricular scar, and myocardial oxygenation;
and 2) evaluate the diagnostic performance of BOLD imaging in the clinical setting.
Methods BOLD and first-pass perfusion images were acquired at rest and stress (4 to 5 min intravenous adenosine,
140 g/kg/min) and assessed quantitatively (using a BOLD signal intensity index [stress/resting signal inten-
sity], and absolute quantification of perfusion by model-independent deconvolution). A BOLD signal intensity in-
dex threshold to identify ischemic myocardium was first determined in a derivation arm (25 CAD patients and
20 healthy volunteers). To determine diagnostic performance, this was then applied in a separate group com-
prising 60 patients with suspected CAD referred for diagnostic angiography.
Results Prospective evaluation of BOLD imaging yielded an accuracy of 84%, a sensitivity of 92%, and a specificity of
72% for detecting myocardial ischemia and 86%, 92%, and 72%, respectively, for identifying significant coronary
stenosis. Segment-based analysis revealed evidence of dissociation between oxygenation and perfusion
(r  0.26), with a weaker correlation of quantitative coronary angiography with myocardial oxygenation
(r  0.20) than with perfusion (r  0.40; p  0.005 for difference). Hypertension increased the odds of an
abnormal BOLD response, but diabetes mellitus, hypercholesterolemia, and the presence of ventricular scar
were not associated with significant deoxygenation.
Conclusions BOLD imaging provides valuable insights into the pathophysiology of CAD; myocardial hypoperfusion is not nec-
essarily commensurate with deoxygenation. In the clinical setting, BOLD imaging achieves favorable accuracy for
identifying the anatomic and functional significance of CAD. (J Am Coll Cardiol 2012;59:1954–64) © 2012 by
the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2012.01.055Determining the presence and severity of myocardial isch-
emia is a key goal in the effective management of coronary
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May 29, 2012:1954–64 BOLD MRI in Coronary Artery Diseasebenefits of ischemia-driven revascularization are well recog-
nized (1,2).
It is now well established that the anatomic appear-
ances of epicardial coronary arteries are poorly predictive
of myocardial ischemia (3). Therefore, current guidelines
recommend concurrent assessment of the functional severity
of coronary stenosis to guide revascularization (4). In the clinical
etting, a number of imaging methods are available, including
uclear imaging techniques, echocardiography, and cardiovas-
ular magnetic resonance (CMR). Such modalities assess
erfusion and contractile abnormalities, but these serve as
urrogates of myocardial ischemia: ischemia per se is not
easured.
See page 1965
A novel CMR application, blood oxygen level–dependent
(BOLD) imaging, now offers the possibility of detecting
ischemia more directly. This technique exploits the para-
magnetic properties of the body’s intrinsic contrast agent,
hemoglobin (5). The transition from diamagnetic oxyhemo-
globin to paramagnetic deoxyhemoglobin induces magnetic
susceptibility differences, resulting in a change in magnetic
resonance signal intensity and thereby generating oxygen-
dependent contrast (6). Because ischemia is the initiator of
the ischemic cascade, theoretically BOLD imaging could
prove sensitive for detecting CAD. Previous studies have
validated BOLD imaging against invasive measurement of
perfusion and microcirculatory oxygenation in animal mod-
els (7–15). The potential benefits of BOLD imaging were
also demonstrated in recent human studies (16–20). How-
ever, many early studies were hampered by limitations
inherent in the BOLD sequences, namely, low signal-to-
noise ratios, long acquisition times, and the occurrence of
imaging artifacts that may mimic regional deoxygenation
(21,22). The recently developed steady-state free precession
(SSFP) sequence circumvents many of these difficulties and
has been validated in animal models with promising initial
results (12,14,15,23). Currently, there are limited data on
human subjects, and the potential clinical utility of this
technique in subjects with suspected CAD remains
uncertain.
Therefore, the first objective of our study was to investi-
gate the diagnostic performance of BOLD imaging in the
clinical setting. The second objective was to capitalize on
the multiparametric capability of CMR and apply first-pass
perfusion and late gadolinium enhancement (LGE) imag-
ing in conjunction with BOLD assessment to examine the
pathophysiological relationship of myocardial tissue oxygen-
ation with myocardial perfusion, coronary stenosis, ventric-
ular scar, and cardiac risk factors.
Methods
Study population. To determine an appropriate BOLD
threshold, 25 patients with known CAD (single- or 2-vesseldisease) and 20 normal volun-
teers (with minimal coronary risk
factors and no history of CAD)
were first studied. For the pro-
spective application of BOLD
imaging, we recruited an addi-
tional 60 subjects who were
scheduled for elective diagnostic
angiography for investigation of
exertional chest pain as part of
routine clinical care.
Exclusion criteria were recent
myocardial infarction (within 7
days), unstable coronary syndromes,
contraindications to CMR (severe
claustrophobia, metallic implants
including pacemakers, defibrilla-
tors, cerebral aneurysm clips, ocular
metallic deposits), contraindications
to adenosine (second- or third-
degree atrioventricular block, ob-
structive pulmonary disease, dipy-
ridamole use) and contraindications to gadolinium (anaphylaxis,
estimated glomerular filtration rate 60 ml/min). Patients
underwent CMR imaging in the 2 weeks before undergoing
coronary angiography.
CMR protocol. Subjects were asked to avoid agents that
could antagonize the effects of adenosine (e.g., caffeine,
methylxanthines) for at least 24 h before the CMR scan. All
participants gave written informed consent, and the study
was approved by the regional ethics committee.
Each patient underwent CMR examination at 3-T (TIM
Trio, Siemens Medical Solutions, Erlangen, Germany)
using an anterior 4-element phased-array coil and a posterior
phased-array surface coil. From standard piloting, short-axis cine
images covering the left ventricle were acquired using a retrospec-
tive electrocardiography (ECG)-gated SSFP sequence (echo time,
1.5 ms; repetition time, 3 ms; flip angle, 60°).
For BOLD imaging, patients were monitored by ECG,
sphygmomanometry, and pulse oximetry. Six consecutive
mid ventricular images were acquired from the same short-
axis slice using a T2-prepared ECG-gated SSFP sequence
(echo time, 1.43 ms; repetition time, 2.86 ms; T2 prepara-
tion time, 40 ms; matrix, 168  192; slice thickness, 8 mm;
flip angle, 44°) at rest. If required, frequency scouting and
shim adjustments were performed to minimize off-
resonance artifacts. For stress imaging, after 2 min of
intravenous adenosine (140 g/kg/min), 4 to 6 stress
OLD images were consecutively acquired in the same
hort-axis plane. Immediately after stress BOLD imaging (4
o 5 min after commencing the adenosine infusion), first-
ass perfusion imaging was performed in the same short-
xis plane as for BOLD imaging, using an ECG-gated
1-weighted fast gradient echo sequence (echo time, 1.04
s; repetition time, 2 ms; voxel size, 2.1  2.6  8 mm3),
Abbreviations
and Acronyms
BOLD  blood oxygen
level–dependent
CAD  coronary artery
disease
CMR  cardiovascular
magnetic resonance
ECG  electrocardiography
LGE  late gadolinium
enhancement
MBF  myocardial blood
flow
MBV  microvascular
blood volume
ROC  receiver-operating
characteristic
SI  signal intensity
SSFP  steady-state free
precessionand a peripheral bolus injection of a gadolinium-based
1956 Arnold et al. JACC Vol. 59, No. 22, 2012
BOLD MRI in Coronary Artery Disease May 29, 2012:1954–64contrast agent (0.04 mmol/kg; Gadodiamide, Omniscan,
GE Healthcare Amersham, United Kingdom), followed by
a 15-ml bolus of normal saline (rate 6 ml/s). After 20 min,
the same sequence was repeated without adenosine to obtain
resting perfusion images.
For delayed enhancement imaging, an additional bolus of
Gadodiamide (0.05 mmol/kg) was injected, and after 5 min,
images were acquired in the 3 long axes and in the short axis
plane to obtain coverage of the entire left ventricle using an
ECG-gated T1-weighted segmented inversion recovery
turbo fast low-angle shot sequence (echo time, 4.8 ms; voxel
size, 1.4  2.4  8 mm; flip angle, 20°). The inversion time
was adjusted to achieve optimal nulling of noninfarcted
myocardium.
Coronary angiography. In the 6 weeks before CMR ex-
amination for known CAD patients, and in the 2 weeks
after CMR examination of subjects with suspected CAD,
all subjects underwent coronary angiography using standard
techniques. Images of the coronary arteries were obtained in
multiple projections, with avoidance of overlap of side
branches and foreshortening of relevant coronary stenoses.
CMR analysis. For analysis of myocardial perfusion, signal
intensity (SI) curves were generated by tracing endocardial
and epicardial contours (QMass, version 6.2.3, Medis Med-
ical Imaging Solutions, Leiden, the Netherlands), which
were manually corrected for cardiac displacement. The
myocardium was divided into 6 equiangular segments in
accordance with the American Heart Association 17-
Baseline Clinical CharacteristicsTable 1 Baseline Clinical Characteristics
Deriva
Known CAD
(n  25)
H
Men 15 (60)
Age, yrs 62 8
Risk factors
Current smoker 6 (24)
Ex-smoker 8 (32)
Hypertension 13 (52)
Hypercholesterolemia 14 (56)
Diabetes mellitus 4 (16)
Family history 15 (60)
Medications
Aspirin 24 (96)
Statin 23 (33)
Beta-blocker 17 (33)
Calcium blocker 8 (32)
Nitrate 4 (16)
ACE inhibitor/ARA 10 (40)
Volumetric indices
Ejection fraction, % 65 10
End-diastolic volume index, ml/m2 71 16
End-systolic volume index, ml/m2 2 14
Stroke volume index, ml/m2 46 8
Mass index, g/m2 62 22Values are n (%) or mean  SD.
ACE  angiotensin-converting enzyme; ARA  angiotensin receptor antagosegment model (24). A region of interest was placed within
the cavity of the left ventricle, excluding the myocardium
and papillary muscles. Quantitative perfusion analysis was
performed as previously described (25,26). Absolute myo-
cardial blood flow (MBF) (in milliliters per minute per
gram) was calculated for each myocardial segment by
model-independent deconvolution of myocardial and arte-
rial input SI curves. Reproducibility data from our group
using this technique have previously been published (27).
Perfusion analysis was performed by 2 operators (J.R.A. and
M.J.H.), blinded to clinical information, angiographic data.
and BOLD analysis.
For BOLD assessment, endocardial and epicardial con-
tours were traced manually, with correction of cardiac
motion (QMass version 6.2.3, Medis Medical Imaging
Solutions). The myocardium was then subdivided into 6
equiangular segments (inferior septum, anterior septum,
anterior, anterolateral, inferolateral, and inferior), corre-
sponding to the mid ventricular slice in the American Heart
Association 17-segment model. The mean SI within each
segment was obtained, both at rest and stress, and corrected
for variations in heart rate, as previously described (28). The
BOLD SI index was derived by dividing the change in SI
from rest to stress by rest SI ([stress SI  rest SI]/rest SI).
No segments were excluded from analysis. Reproducibility
data from our group using this technique were previously
published (19). BOLD analysis was performed by a single
operator (J.R.A., blinded to clinical information, angio-
m Validation Arm
y Volunteers
 20)
Entire Group
(n  57)
No CAD
(n  18)
CAD
(n  39)
2 (60) 44 (77) 8 (44) 36 (92)
3 7 61 9 60 8 62 10
1 (5) 7 (12) 4 (22) 3 (8)
2 (10) 21 (37) 3 (17) 18 (46)
0 (0) 27 (47) 7 (39) 20 (51)
0 (0) 27 (47) 9 (50) 18 (46)
0 (0) 12 (21) 3 (17) 9 (23)
2 (10) 25 (44) 9 (50) 16 (41)
0 (0) 45 (79) 13 (72) 32 (82)
0 (0) 48 (84) 15 (83) 33 (85)
0 (0) 36 (63) 8 (44) 28 (72)
0 (0) 11 (19) 5 (28) 6 (15)
0 (0) 11 (19) 3 (17) 8 (21)
0 (0) 28 (49) 7 (39) 21 (54)
6 7 64 14 68 10 63 15
2 16 77 14 69 9 81 14
5 9 29 13 23 8 32 14
6 9 48 7 47 7 49 7
4 12 62 16 62 20 63 15tion Ar
ealth
(n
1
5
6
7
2
4
8nist; CAD  coronary artery disease.
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analyses).
Analyses of left ventricular function (J.R.A.) and LGE
(T.D.K.) were performed blinded to clinical information,
angiographic data, and analysis of BOLD and perfusion
data. For analysis of left ventricular function, the short-axis
SSFP images were analyzed using customized software
(CMRTools, Cardiovascular Imaging Solutions Ltd., Lon-
don, United Kingdom). For analysis of LGE images, areas
of hyperenhancement were assessed visually as present or
absent, and with estimation of the transmural extent of
LGE.
Angiographic analysis. Quantitative coronary angiography
was performed by 2 operators (N.S. and R.P.C.) blinded to
clinical information and CMR data. Diameters of reference
and stenotic coronary arteries were measured by a
computer-assisted quantitative method (Quantcor Coronary
Analysis, Siemens Medical Solutions). The contrast-filled
catheter was used for image magnification calibration.
Significant CAD was defined angiographically as the pres-
ence of at least 1 stenosis of 50% diameter in any of the
main epicardial coronary arteries or their branches with a
diameter of2 mm. Each myocardial segment was assigned
to a coronary artery territory according to standard criteria
(24). For CAD patients in the derivation arm, attention was
paid to coronary dominance and the location of any coro-
nary stenoses in relation to the mid ventricular slice of the
American Heart Association 17-segment model: segments
Figure 1 Relationship of BOLD SI Change and Hyperemic MBF
The BOLD SI index increases with increasing MBF (r  0.26), but with a plateau a
mixed model to adjust for intrapatient correlations. The BOLD signal intensity chan
line). The dashed lines provided the 95% confidence limits for prediction. The ove
represented by a smoothing spline, was p  0.001. BOLD  blood oxygen level–dwere labeled as stenosed if subtended by significant coronary
stenoses or remote if there were no significant stenoses
proximal to the mid ventricular level.
Statistical analysis. Data analysis was performed using
SPSS 15.0 for Windows (SPSS Inc., Chicago, Illinois) and
Medcalc 9.5.2.0 (Mariakerke, Belgium). Normally distrib-
uted variables are presented as mean  SD. Non-normally
istributed data are presented as median and interquartile
ange (25th and 75th percentiles). Continuous variables
ere tested for normal distribution using the D’Agostino-
earson test. Comparisons among the 3 groups of myocar-
ial segments were performed with analysis of variance or
he Kruskal-Wallis test, as appropriate.
To investigate the diagnostic performance of BOLD
maging, first, the receiver-operating characteristic (ROC)
urve analysis was applied in the derivation group to identify
hyperemic MBF cutoff defined using a50% threshold of
oronary stenosis. The optimal cut-point was defined as that
iving rise to the highest sum of sensitivity and specificity.
egments were classified as ischemic or nonischemic using
his threshold, and a corresponding BOLD SI index thresh-
ld was determined using ROC curve analysis. This prede-
ermined cutoff value for the BOLD SI index was then
pplied in the validation group to determine sensitivity,
pecificity, and diagnostic accuracy of BOLD in the iden-
ification of ischemia. The ability of BOLD imaging to
dentify significant coronary stenosis was also determined, as
as that of first-pass perfusion imaging.
r MBF (3 ml/min/g). The solid line is derived from a generalized additive
s represented as a smooth function (smoothing spline) of hyperemic MBF (solid
nificance of the nonlinear association between BOLD signal and hyperemic MBF,
ent; MBF  myocardial blood flow; SI  signal intensity.t highe
ge wa
rall sig
epend
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on the cutoff value from the ROC curve analysis) with
clinical, segmental LGE, and perfusion variables was ana-
lyzed with a mixed-effects logistic regression model, using
the package lme4 in the R statistical computing environ-
ment (R: A Language and Environment for Statistical
Computing, R Foundation for Statistical Computing, Vi-
enna, Austria, 2010). Within-patient correlation of mea-
surements was modeled with a compound symmetry cova-
riance structure for the random effects, using the patient
identifier as a variable to group data. The odds ratios and
their confidence intervals were calculated from the esti-
mated regression coefficients for the fixed effects (glmer in R
package lme4).
Generalized additive mixed models (gamm in the R
package mgcv) were used to examine data trends between
the BOLD SI index and hyperemic MBF, both measured at
the segmental level. A smoothing spline was used as a
nonparametric representation of the nonlinear relationship
between BOLD SI index and hyperemic MBF as a predic-
tor. The optimal amount of smoothing was determined by
generalized cross-validation. The nonparametric model
analysis was chosen here due to the absence of any accepted
functional model for the (nonlinear) relationship between
the BOLD SI index and hyperemic MBF and because
standard linear regression would represent a gross oversim-
plification. The direction and strength of the association
between 2 variables were assessed with the Spearman
correlation coefficient. Permutation tests of the correlations
were performed to account for correlations of repeated
measures, using corrperrm in the R package. The tests are
Figure 2 Relative Frequency of Abnormal BOLD SI Change With
The likelihood of abnormal BOLD SI change decreased with increasing hyperemic M
the error bars represent 95% confidence limits, obtained by the bootstrap methodbased on combining the Spearman correlations or p values
for all possible combinations of repeated measures for the 2
measured variables. Correlation coefficients were compared
following the Fisher Z transformation.
Results
Study population. Table 1 outlines baseline characteristics
for the study participants. In the derivation arm of the study,
20 healthy volunteers and 25 CAD patients were recruited.
In the latter, 11 patients (44%) had angiographically signif-
icant left anterior descending artery disease, 8 (32%), left
circumflex artery disease, and 8 (32%), disease of the right
coronary artery. Based on coronary anatomy, 54 myocardial
segments were supplied by stenosed vessels (stenosed seg-
ments) and 96 segments, by vessels with minimal or no
disease (segments remote to ischemia). Myocardial seg-
ments (n  120) from normal volunteers were labeled as
normal segments. In all subjects in the derivation arm of the
study, there was no LGE in the slice positions correspond-
ing to perfusion or BOLD imaging.
In the validation arm of the study, a total of 60 patients
were recruited. Two subjects could not complete the scan
due to claustrophobia, and in 1 subject, the study protocol
was not carried out due to the finding of severe dilated
cardiomyopathy on cine imaging. One subject requested ces-
sation of the scan after stress BOLD imaging but before stress
perfusion imaging could be performed (thus, 57 patients
available for BOLD analysis, and 56 patients for perfusion
analysis). No clinical cardiac events occurred in the period
between the scans and coronary angiography. In total, 39 of 57
easing Quintiles of Hyperemic MBF
 0.0005 for linear trend). Coefficients derived from a logistic regression model;
sampling at the patient level. Abbreviations as in Figure 1.Incr
BF (p
, with
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May 29, 2012:1954–64 BOLD MRI in Coronary Artery Diseasepatients (68%) had angiographically defined significant CAD
(stenosis of50%): 60% with significant left anterior descend-
ing artery disease, 26% with left circumflex disease, and 33%
with right coronary artery disease. LGE was present in 31% of
patients (mean transmurality 52  23%).
ROC curve analysis. In the derivation group, using quan-
titative coronary angiography as the gold standard, ROC
Figure 3 Segmental Variation of Percent BOLD SI Index in Volu
Relative to anterior segments, BOLD SI index was significantly lower in anterolater
account for within-patient correlations. Abbreviations as in Figure 1.
Figure 4 Impact of LGE on Hyperemic MBF and BOLD SI index
The presence of LGE was associated with a significant reduction in hyperemic MB
with a linear mixed-effects model for hyperemic MBF or BOLD SI, with the presenc
other abbreviations as in Figure 1.curve analysis defined a cutoff value for stress MBF 1.8
ml/min/g (area under the curve 0.77 0.03, p 0.0001) to
identify segments subtended by 50% stenosis. Using this
as the threshold of ischemia, ROC curve analysis identified
a BOLD SI index threshold of 2.64% (area under the curve
0.62  0.04, p  0.0009) to distinguish ischemic from
nonischemic myocardium on a per-segment basis.
rs and Subjects With Normal Coronary Angiography
inferolateral segments, using a linear mixed effects model for BOLD SI to
0.0001) but no difference in the BOLD SI index (p  0.26). p Values obtained
bsence of LGE as a categorical predictor. LGE  late gadolinium enhancement;ntee
al andF (p 
e or a
p
g
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BOLD MRI in Coronary Artery Disease May 29, 2012:1954–64Relationship among tissue oxygenation, perfusion, and
coronary stenosis. Segmental data from all subjects were
ooled to investigate the relationship between tissue oxy-
enation and MBF. Figure 1 shows the relationship be-
tween the BOLD SI index and hyperemic MBF. The
BOLD SI index increased with increasing MBF (r  0.26),
but with a plateau at higher MBF (3 ml/min/g). How-
ever, there was evidence of dissociation between the BOLD
SI index and MBF, with 50% of hypoperfused segments
(1.8 ml/min/g) demonstrating no evidence of deoxygen-
ation (BOLD SI index2.64%), and 23% of segments with
MBF 1.8 ml/min/g showing some evidence of deoxygen-
ation. Nonetheless, the likelihood of abnormal BOLD SI
change decreased as hyperemic MBF increased (Fig. 2).
Both the BOLD SI index and hyperemic MBF decreased
with increasing stenosis, but there was a weaker correla-
tion with myocardial oxygenation (r  0.20, p  0.001)
than with perfusion (r  0.40, p  0.001; p  0.005 for
difference).
Figure 5 ORs for Abnormal BOLD Response
Odds ratios (ORs) for abnormal BOLD response (2.64%) for perfusion, quantitative c
DM  diabetes mellitus; OR  odds ratio; other abbreviations as in Figure 1.Impact of segment location, LGE, and cardiac risk
factors on tissue oxygenation. Assessment of the BOLD
SI index in normal volunteers and patients with normal
coronary angiography revealed that the BOLD SI index
varies by myocardial sector, with lower values in anterolat-
eral and inferolateral segments (p 0.0003 and p 0.0033,
respectively, compared with the BOLD SI index in anterior
segments) (Fig. 3).
Figure 4 shows the relationships between the presence of
LGE and both the BOLD SI index and MBF. Whereas the
presence of LGE was associated with significantly lower
MBF (p  0.0001), there was no significant difference in
the BOLD SI index between segments with and without
LGE (p  0.26). Figure 5 depicts the effects on an
abnormal BOLD response of hyperemic MBF, LGE, and
other cardiac risk factors, all included simultaneously as
predictors in a multivariate logistic regression model. The
odds of an abnormal BOLD response approximately dou-
bled with the presence of hypertension (p  0.025), and a
y angiography (QCA) stenosis 50%, LGE, and cardiac risk factors and medications.oronar
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May 29, 2012:1954–64 BOLD MRI in Coronary Artery Diseasequantitative coronary angiography stenosis 50% (p 
.0048), although it was reduced by approximately one-
ourth for each 1-ml/min/g increment of the hyperemic
BF response (p  0.025). There was a trend for smoking
p  0.088) to increase the odds of an abnormal BOLD
esponse, whereas LGE (p 0.97), hypercholesterolemia (p
.15), and diabetes mellitus (p  0.77) did not significantly
hange the odds of an abnormal BOLD response.
BF and BOLD SI index in normal volunteers and
ubjects with known CAD. Table 2 shows the MBF and
OLD SI changes for the 3 groups of myocardial segments
n the derivation arm of the study. In normal volunteers,
BF increased from 0.88  0.28 ml/min/g at rest to
.86  0.98 ml/min/g during hyperemia (p  0.0001). In
AD patients, there was a blunted increase in hyperemic
ow in diseased segments, from 0.76  0.22 ml/min/g at
est to 1.59  0.68 ml/min/g during stress (p  0.0165 for
hange). Segments remote from ischemia showed an inter-
ediate stress MBF between those of normal and stenosed
egments (Table 2).
Table 2 also shows the relative BOLD SI changes. In
ormal volunteers, the mean relative increase in the BOLD
I index was 12%. However, in diseased segments, the
elative BOLD SI increase was significantly lower (mean
%), mirroring the behavior of stress MBF. Segments
emote to ischemia demonstrated an intermediate increase
n BOLD SI index, as reported in previous studies
16,19,20). Pooled segmental data from all subjects (N 
02) confirmed this finding.
rospective application of BOLD and perfusion imaging.
sing quantitative coronary angiography as the reference
tandard for determining anatomically significant CAD, 39
f 57 subjects (68%) had significant CAD. BOLD imaging
chieved an accuracy of 86%, a sensitivity of 92%, and a
pecificity of 72% for identifying significant coronary ste-
osis, compared with 91%, 92%, and 89%, respectively, for
erfusion imaging. Sensitivity, specificity, and predictive
alues for each technique by coronary territory are listed in
able 3. Figure 6 demonstrates patient examples of perfu-
ion and BOLD imaging.
Using CMR perfusion imaging as the reference standard
or determining functionally significant CAD, 38 of 56
ubjects (68%) had evidence of ischemia (as defined by
yperemic MBF 1.8 ml/min/g). BOLD imaging using
he predetermined cutoff of 2.64% achieved a diagnostic
MBF and BOLD SI in Stenosed, Remote, and NTable 2 MBF and BOLD SI in Stenosed, Re
Stenosed
(n  54)
Resting MBF, ml/min/g 0.76 0.22*
Hyperemic MBF, ml/min/g 1.59 0.68*‡
BOLD SI, % 4.45 9.46*‡
*p  0.05 for comparison of stenosed and normal segments. †p  0
for comparison of stenosed and remote to ischemia segments.
BOLD SI  change in blood oxygen level–dependent signal intensccuracy of 84% for the identification of ischemic myocar-
N
aium, with a sensitivity of 92% and a specificity of 72%.
ensitivity, specificity, and predictive values for BOLD
maging to identify ischemia by coronary territory are listed
n Table 4.
On a per-segment basis, agreement between BOLD and
erfusion imaging for the overall diagnosis of CAD was
6% (kappa  0.29). On a per-subject basis, agreement was
4% (kappa  0.66).
iscussion
OLD MRI provides valuable insights into the pathophysi-
logy of CAD. In this study involving multiparametric, high-
l Segments, and Normal Segments
Remote
(n  96)
Normal
(n  120) p Value
.76 0.22† 0.88 0.28 0.001
.97 0.68† 2.86 0.98 0.001
.00 8.88† 12.00 11.31 0.001
comparison of remote to ischemia and normal segments. ‡p  0.05
 myocardial blood flow.
Performance of BOLD and Perfusion Imaging forD tecting Anatomically Significant CAD Using QCAas the Reference St ndard
Table 3
Perform ce of BOLD and Perfusi n Imaging for
Detecting Anatomically Significant CAD Using QCA
as the Reference Standard
BOLD Perfusion
% n/N 95% CI % n/N 95% CI
CAD
Sensitivity 92 36/39 79–98 92 35/38 79–98
Specificity 72 13/18 47–90 89 16/18 65–99
DA 86 49/57 74–94 91 51/56 80–97
NPV 81 13/16 54–96 84 16/19 46–66
PPV 88 36/41 74–96 95 35/37 82–99
LAD
Sensitivity 71 24/34 52–85 70 23/33 51–84
Specificity 70 16/23 47–87 87 20/23 66–97
DA 70 40/57 57–82 77 43/56 64–87
NPV 62 16/26 41–80 67 20/30 47–83
PPV 77 24/31 59–90 88 23/26 70–98
LCx
Sensitivity 67 10/15 38–88 73 11/15 45–92
Specificity 81 34/42 66–91 93 38/41 80–98
DA 77 44/57 64–87 88 49/56 76–95
NPV 87 34/39 73–96 90 38/42 77–97
PPV 56 10/18 31–78 79 11/14 49–95
RCA
Sensitivity 89 17/19 67–99 95 18/19 74–100
Specificity 74 28/38 57–87 76 28/37 59–88
DA 79 45/57 66–89 82 46/56 70–91
NPV 93 28/30 78–99 97 28/29 82–100
PPV 63 17/27 42–81 67 18/27 46–83
n  57 for BOLD and n  56 for perfusion imaging as 1 subject (with single-vessel disease in the
LAD) underwent BOLD evaluation but not stress perfusion imaging.
BOLD blood oxygen level–dependent; CAD coronary artery disease; CI confidence interval;
DA  diagnostic accuracy; LAD  left anterior descending artery; LCx  left circumflex artery;ormamote
0
1
8
.05 forPV  negative predictive value; PPV  positive predictive value; QCA  quantitative coronary
ngiography; RCA  right coronary artery.
1962 Arnold et al. JACC Vol. 59, No. 22, 2012
BOLD MRI in Coronary Artery Disease May 29, 2012:1954–64field strength CMR, we demonstrate that hypoperfusion is not
necessarily commensurate with deoxygenation, notably in seg-
ments with myocardial scar, where perfusion is reduced but
without associated deoxygenation. Furthermore, although hy-
pertension increases the odds of abnormal BOLD response,
diabetes mellitus and hypercholesterolemia are not associated
with significant deoxygenation. Although downstream hyper-
emic flow decreases with increasing coronary stenosis, the
correlation between quantitative coronary angiography and
deoxygenation is weaker. Nonetheless, our data demonstrate
that this technique can identify the presence and functional
significance of CAD with favorable accuracy.
Angiographic appearances do not reliably indicate the he-
modynamic significance of a lesion. As demonstrated in
previous studies, we also found that the BOLD effect in remote
segments in patients with CAD had a level intermediate
between stenosed segments and normal myocardium in volun-
teers, suggesting that not only epicardial flow limitation but
also microvascular function may play an important role in the
BOLD response (16,19). This may also explain the lower
correlation of the BOLD SI index and MBF than in previous
studies involving healthy canines with coronary hydraulic
occluders (12,14). Our data reveal that tissue oxygenation
correlates poorly with quantitative coronary angiography and
that this relationship is even weaker than that between tissue
perfusion and stenosis severity. Interestingly, we also found
that microvascular perfusion may itself be uncoupled from
tissue oxygenation; a significant proportion of hypoperfused
segments did not show evidence of deoxygenation (19). This
Figure 6 Patient Examples of BOLD Imaging
From left to right, short-axis rest and stress BOLD images, plot of segmental BOLD S
significant left circumflex disease; subject #2, left anterior descending artery stenosisresult highlights a potential limitation of perfusion imagingtechniques, namely, that hypoperfusion is not necessarily com-
mensurate with deoxygenation or ischemia. This is best exem-
plified in segments with LGE, where the hyperemic response
is predictably reduced; by contrast, the BOLD SI index in
these segments remains unchanged (Fig. 3). This may reflect
the presence of nonischemic but viable tissue in the vicinity of
scar, which returns a normal BOLD response. It is also
possible that to avert ischemia in the face of hypoperfusion,
there may be a down-regulation of energy-using processes, as
has been postulated to occur in hibernating myocardium (29).
There may exist a degree of physiological reserve, whereby
perfusion may decrease within a safety margin, without corre-
sponding deoxygenation.
In the context of adenosine stress testing, microvascular
blood volume (MBV) may also be an important factor
contributing to the dissociation between perfusion and the
BOLD SI index. Although increased MBV may serve as a
mechanism for meeting increased oxygen demand, MBF
and MBV may become decoupled during vasodilator stress,
with the occurrence of capillary derecruitment (9,16,30–32).
Because the BOLD SI index is determined by absolute
deoxyhemoglobin content, it reflects not only oxygenation,
perfusion, and the balance of myocardial oxygen supply and
demand, but also changes in coronary microvasculature.
Reduced MBF represents only 1 factor contributing to
myocardial ischemia; as a consequence, in pharmacologi-
cally induced hyperemia or in high cardiac workloads, there
may be dissociation between MBF, MBV, oxygen delivery,
and high energy metabolism. Only the latter can be con-
and stress perfusion images (far right). Arrows indicate perfusion defects. Subject #1,
ubject #3, right coronary artery stenosis. Abbreviations as in Figure 1.I index,
; and ssidered a reliable marker of cellular ischemia; thus, both
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May 29, 2012:1954–64 BOLD MRI in Coronary Artery DiseaseMBF and BOLD measurements may have potential limi-
tations in the detection of true myocardial ischemia.
In our study, we elected to compare BOLD imaging with
CMR perfusion imaging, which has the advantage of superior
spatial resolution compared with alternative imaging modali-
ties. This approach also ensured precise spatial coregistration of
BOLD and perfusion images and that both imaging modalities
were performed under the same hemodynamic conditions. By
contrast, previous studies (involving positron emission tomog-
raphy or single-photon emission computed tomography) in-
variably conducted the 2 imaging protocols under differing
hemodynamic states (17,19). Our study is also the first human
study to compare BOLD imaging with absolute quantification
of perfusion with CMR, which itself has been shown to be
superior to semiquantitative methods (33).
The BOLD SI index threshold defined in our study
(2.64%) is comparable to the thresholds defined in previ-
ous human studies (Jahnke et al. [17],2.7%; Karamitsos et
l. [19], 3.74%; Friedrich et al. [20], 1.2% [for 75%
tenoses]). Previous studies of BOLD imaging in human
ubjects used populations with known CAD or high prev-
lence of CAD, which may distort assessment of sensitivity
nd specificity (17,19,20). Furthermore, to evaluate diag-
ostic performance, BOLD SI index thresholds were ap-
lied within the same study population from which they
ere determined. This approach may have led to overly
Performance of BOLD Imaging for DetectingFunctionally Significant CAD Using S ress PerfusionCMR as the Reference Standard
Table 4
P rform ce of BOLD Imaging for Detecting
Functionally Significant CAD Using Stress Perfusion
CMR as the Reference Standard
% n/N 95% CI
CAD
Sensitivity 92 35/38 79–98
Specificity 72 13/18 47–90
DA 86 48/56 74–94
NPV 81 13/16 54–96
PPV 88 35/40 73–96
LAD
Sensitivity 79 23/29 60–92
Specificity 74 20/27 54–89
DA 77 43/56 64–87
NPV 77 20/26 56–91
PPV 77 23/30 58–90
LCx
Sensitivity 67 10/15 38–88
Specificity 80 33/41 65–91
DA 77 43/56 64–87
NPV 87 33/38 72–96
PPV 56 10/18 31–78
RCA
Sensitivity 82 23/28 63–94
Specificity 89 25/28 72–98
DA 86 48/56 74–94
NPV 83 25/30 65–94
PPV 88 23/26 70–98
Abbreviations as in Tables 1 and 3.ptimistic estimates of the sensitivity and specificity v17,19,20). In our study, we used an independent derivation
roup to determine the BOLD SI index threshold, and to
etermine diagnostic performance, this threshold was then
pplied prospectively in a separate population with sus-
ected CAD. This 2-step approach enabled a more robust
ssessment of diagnostic performance: our results reveal that
espite only imaging 1 myocardial short-axis slice, BOLD
MR achieves high sensitivity (92%), but moderate speci-
city (72%). The latter may relate in part to the persistence
f imaging artifact. Although the use of SSFP BOLD
maging at high field strength achieves higher signal-to-
oise ratios and shorter acquisition times than alternative
equences, it remains susceptible to off-resonance effects
ssociated with local field inhomogeneities. All previous
tudies applied a single BOLD threshold to all segments,
ith the inherent assumption that the BOLD SI index is
niform in all myocardial sectors (16,17,19,20). However,
n our study, segmental data from subjects without estab-
ished CAD reveal that the BOLD SI index is lower in the
nferolateral and anterolateral segments. Whether this rep-
esents a physiological phenomenon or a limitation of the
OLD technique (such as altered signal with varying
istance from the surface coil) warrants further investiga-
ion. Against the latter, normalization of BOLD signal by
ormalizing stress SI by the resting SI in the corresponding
egment should theoretically counter any regional variation
n signal. Nonetheless, the observation of variation in the
ormalized BOLD SI index by sector suggests that it may
e advantageous to use separate thresholds for different
yocardial sectors, and this approach may improve diag-
ostic specificity and accuracy.
tudy limitations. In our study, although image quality
as generally good, artifacts could not always be resolved
ith frequency and shim adjustments, and this may have
ontributed to the limited specificity of BOLD imaging.
nvasive angiography was not performed in the normal
olunteers, although significant CAD was unlikely given the
nding of normal hyperemic flows in these subjects. Our
tudy is also limited by the lack of invasive hemodynamic
easures; validation of BOLD imaging against fractional
ow reserve is an important goal in future studies. The use
f a single mid ventricular slice for BOLD imaging is a
urther weakness of our study. It is possible that distal
oronary disease may have been missed. In future studies,
iagnostic performance will be improved with the use of
ultislice imaging with parallel imaging techniques and
rtifact reduction methods (20,34).
onclusions
he noninvasive assessment of myocardial oxygenation by
OLD imaging offers valuable insights into the pathophysi-
logy of CAD. Our data indicate that hypoperfusion may not
ecessarily imply cellular ischemia because there is apparent
issociation between myocardial tissue oxygenation and micro-
ascular blood flow. Our study also provides prospective
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BOLD MRI in Coronary Artery Disease May 29, 2012:1954–64evaluation of BOLD imaging in the clinical setting. Although
the results are promising, we identify a number of shortcom-
ings that need to be addressed before this technique can fulfill
a diagnostic role in the clinical setting.
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